Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6605913rdf:typepubmed:Citationlld:pubmed
pubmed-article:6605913lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C0036536lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C0036537lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C0020861lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C0031586lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:6605913lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:6605913pubmed:issue1lld:pubmed
pubmed-article:6605913pubmed:dateCreated1984-1-7lld:pubmed
pubmed-article:6605913pubmed:abstractTextHuman B-cell lines were screened for stimulation of immunoglobulin production by incubation with lymphokine (LK) or tumor promoter, phorbol myristic acetate (PMA). One group of lines had essentially no immunoglobulin-secreting cells (ISC) under any condition (less than 0.01%), detected by a reverse plaque assay. Another group of lines had high levels of ISC (greater than 5%) which was not increased substantially by inducing agents. In a third group of IgM and IgG lines, there were intermediate levels of ISC which could be increased by LK, PMA or both agents. No evidence for isotype switching in a number of stimulated IgM and IgG cell lines was detected. Clone SKW6.4 of an IgM line was highly responsive to a B-cell-inducing factor (BIF) in LK. BIF for SKW6.4 and IgG line ARH-77 was weakly binding to DEAE cellulose, about 20,000 mol. wt., and separable from IL-2 by blue agarose chromatography. IL-2 did not stimulate secretion in SKW6.4 with or without purified BIF. In Clone SKW6.4, BIF stimulated ISC per recovered cell up to 30-fold by day 1 of culture, and these plateau levels of about 6% ISC were maintained for longer than 4 days. Treatment of cells with BIF for less than 1 day was sufficient to produce maximum effect on this clone for the succeeding 4 days. Cells stimulated with BIF and then subcultured at day 3 without BIF showed ISC numbers increasing but at a slower rate than the total population, suggesting that the induced differentiation state is long-lived (half-life of % ISC greater than 6 days) and that ISC produce some daughter ISC.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:6605913pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:languageenglld:pubmed
pubmed-article:6605913pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:citationSubsetIMlld:pubmed
pubmed-article:6605913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6605913pubmed:statusMEDLINElld:pubmed
pubmed-article:6605913pubmed:issn0165-2478lld:pubmed
pubmed-article:6605913pubmed:authorpubmed-author:RalphPPlld:pubmed
pubmed-article:6605913pubmed:authorpubmed-author:WelteKKlld:pubmed
pubmed-article:6605913pubmed:authorpubmed-author:SaikiOOlld:pubmed
pubmed-article:6605913pubmed:authorpubmed-author:MaurerD HDHlld:pubmed
pubmed-article:6605913pubmed:issnTypePrintlld:pubmed
pubmed-article:6605913pubmed:volume7lld:pubmed
pubmed-article:6605913pubmed:ownerNLMlld:pubmed
pubmed-article:6605913pubmed:authorsCompleteYlld:pubmed
pubmed-article:6605913pubmed:pagination17-23lld:pubmed
pubmed-article:6605913pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:meshHeadingpubmed-meshheading:6605913-...lld:pubmed
pubmed-article:6605913pubmed:year1983lld:pubmed
pubmed-article:6605913pubmed:articleTitleIgM and IgG secretion in human B-cell lines regulated by B-cell-inducing factors (BIF) and phorbol ester.lld:pubmed
pubmed-article:6605913pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6605913pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6605913pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6605913pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed